13D Filing: Cetus Capital Ii, Llc and Pernix Therapeutics Holdings, Inc. (PTX)

Page 7 of 10

Page 7 of 10 – SEC Filing

 

233,545 Shares.  Cetus II has the sole power to vote and sole power to dispose of 2,241,177 Shares.  Littlejohn Opportunities Master Fund has the sole power to vote and sole power to dispose of 622,898 Shares.  SG Distressed Fund has the sole power to vote and sole power to dispose of 67,824 Shares.  The information set forth in Item 6 of this statement as amended or supplemented is hereby incorporated herein by reference.

 

(c) On February 21, 2014, (i) Cetus II acquired $8,812,500 principal amount of the Notes, which were convertible into 2,447,916.9 Shares at Cetus IIs option; (ii) Littlejohn Opportunities Master Fund acquired $2,437,500 principal amount of the Notes, which were convertible into 677,083.4 Shares at Littlejohn Opportunities Master Funds option; and (iii) SG Distressed Fund acquired $1,250,000 principal amount of the Notes, which were convertible into 347,222.3 Shares at Cetus IIs option; in each case, from the Issuer in a private placement transaction.

 

The Reporting Persons conducted 32 open market sales in the ordinary course of business within the past 60 days, as set forth in the table attached below:

 

Trade Date

 

Fund

 

Common Stock Sold

 

Price Per Share ($),
before sales commissions

 

3/3/2016

 

LJ Opportunities Fund, LP

 

1,432

 

2.30

 

3/3/2016

 

SG Distressed Fund, LP

 

668

 

2.30

 

3/4/2016

 

LJ Opportunities Fund, LP

 

8,678

 

2.36

 

3/4/2016

 

SG Distressed Fund, LP

 

4,060

 

2.36

 

3/7/2016

 

LJ Opportunities Fund, LP

 

13,843

 

2.36

 

3/7/2016

 

SG Distressed Fund, LP

 

6,476

 

2.36

 

3/8/2016

 

LJ Opportunities Fund, LP

 

750

 

2.32

 

3/8/2016

 

SG Distressed Fund, LP

 

350

 

2.32

 

3/9/2016

 

LJ Opportunities Fund, LP

 

1,568

 

2.32

 

3/9/2016

 

SG Distressed Fund, LP

 

732

 

2.32

 

3/24/2016

 

SG Distressed Fund, LP

 

50,000

 

1.16

 

3/28/2016

 

SG Distressed Fund, LP

 

6,300

 

1.30

 

4/5/2016

 

SG Distressed Fund, LP

 

76,849

 

1.05

 

4/5/2016

 

SG Distressed Fund, LP

 

13,015

 

1.05

 

4/6/2016

 

SG Distressed Fund, LP

 

100,000

 

1.06

 

4/7/2016

 

SG Distressed Fund, LP

 

36,788

 

1.06

 

4/11/2016

 

Cetus Capital II, LLC

 

3,221

 

1.06

 

4/11/2016

 

Cetus Capital III, LP

 

336

 

1.06

 

4/11/2016

 

LJ Opportunities Fund, LP

 

895

 

1.06

 

4/11/2016

 

SG Distressed Fund, LP

 

98

 

1.06

 

4/12/2016

 

Cetus Capital II, LLC

 

353,970

 

0.93

 

4/12/2016

 

Cetus Capital II, LLC

 

176,985

 

0.92

 

4/12/2016

 

Cetus Capital III, LP

 

36,938

 

0.93

 

4/12/2016

 

Cetus Capital III, LP

 

18,469

 

0.92

 

4/12/2016

 

LJ Opportunities Fund, LP

 

49,190

 

0.92

 

4/12/2016

 

LJ Opportunities Fund, LP

 

98,380

 

0.93

 

4/12/2016

 

SG Distressed Fund, LP

 

5,356

 

0.92

 

4/12/2016

 

SG Distressed Fund, LP

 

10,712

 

0.93

 

4/13/2016

 

Cetus Capital II, LLC

 

70,801

 

0.95

 

4/13/2016

 

Cetus Capital III, LP

 

7,379

 

0.95

 

4/13/2016

 

LJ Opportunities Fund, LP

 

19,678

 

0.95

 

4/13/2016

 

SG Distressed Fund, LP

 

2,142

 

0.95

 

 

Except as set forth above, there have been no transactions with respect to the Shares during the sixty days prior to the date of this Schedule 13D by the Reporting Persons or, to their knowledge, by any executive officer or director of the Reporting Persons.

 

6


Follow Pernix Therapeutics Holdings Inc. (NASDAQ:PTX)

Page 7 of 10